Akkodis Named a Leader in ISG Provider Lens(TM) Digital Engineering Services 2026 Reports 
Sinch Mailgun Report: Companies are Leaving Email Performance on the Table 
Datavault AI Further Expands IP Portfolio with New Patent Issuance and Notices of Allowance 
GMG Appoints New Chief Production Growth Officer and Provides Update on Global Production Plans 
TMX Group Announces Agreement to Acquire Cboe Australia and Cboe Canada Enlivex to Present at the Jefferies 2021 Virtual Healthcare Conference
Nes Ziona, Israel, June 03, 2021 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the…
Avadel to Present New Efficacy and Safety Data from Pivotal Phase 3 REST-ON Trial of FT218 at SLEEP 2021
DUBLIN, Ireland, June 03, 2021 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company…
Equillium to Host Conference Call Following Presentation of Data from the EQUATE Study in Acute Graft Versus Host Disease at the EHA2021 Virtual Congress of the European Hematology Association on June 11
Presentation and conference call will include topline data from all cohorts The risk-benefit profile observed…
Monopar Announces New Drug Candidate, MNPR-202, and Enters into Collaboration Agreement with the National University of Singapore for Preclinical Evaluation in Cancer
Development of novel Camsirubicin analog expands Monopar’s therapeutic pipeline WILMETTE, Ill., June 03, 2021 (GLOBE…
Stellanova Therapeutics, Inc. Announces Closing of $15.5 Million Series A Financing
Proceeds will support development of antibody drugs and discovery platform targeting pro-tumorigenic factors produced by…
Oyster Point Pharma Announces Preclinical Study Results and Pipeline Expansion with Enriched Tear Film (ETF™) Gene Therapy to Target Ocular Surface Diseases
Introduction of proprietary ETF™ Gene Therapy and first gene candidate, nerve growth factor (NGF), to…
Motus GI Announces Publication of Pure-Vu® System Clinical Data in Peer-Reviewed Journal BMC Gastroenterology
FORT LAUDERDALE, Fla., June 03, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Krystal Biotech to Participate in Upcoming Investor Conferences
PITTSBURGH, June 03, 2021 (GLOBE NEWSWIRE) — Krystal Biotech Inc., (“Krystal”) (NASDAQ: KRYS), the leader…
Summit Therapeutics’ Upcoming Annual Shareholders’ Meeting
Cambridge, MA, June 03, 2021 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) invites our…
PMV Pharmaceuticals Announces Participation at the Goldman Sachs Annual Healthcare Conference
CRANBURY, N.J., June 03, 2021 (GLOBE NEWSWIRE) — PMV Pharmaceuticals, Inc. (Nasdaq: PMVP), a precision…
Cynata signs Licence Agreement with TekCyte to advance Clinical Trial in Diabetic Foot Ulcers
MELBOURNE, Australia, June 03, 2021 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or…
Histogen Provides Update on its Development Programs and Pipeline Focus
Company to Focus its Regenerative Medicine Technology Platform on Developing Orthopedic Product Candidates HST 003…
Neuronetics to Present at The JMP Securities Life Sciences Conference
MALVERN, Pa., June 03, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical…
Rain Therapeutics Announces Collaboration with Tempus for Genomic Analysis in Planned MDM2-Amplified Phase 2 Basket Trial of RAIN-32
Clinical trial for MDM2 amplified cancers expected to commence in second half of 2021 NEWARK,…
Avicanna Announces Mailing of Management Information Circular and Proposed Board Changes
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES….
ProMIS Neurosciences Files Preliminary Short Form Base Shelf Prospectus
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY,…
Mydecine to Participate in the H.C. Wainwright Psychedelics in Psychiatry and Beyond Conference on June 17th
DENVER, June 03, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE:…
Ocugen Expands COVAXIN™ Commercialization Rights to Include Canada
Ocugen to have exclusive co-development, manufacturing, and commercialization rights to COVAXIN™ in Canada, in addition…
Auris Medical Announces Acquisition of RNA Therapeutics Company and Plans for Strategic Repositioning
Entering field of RNA therapeutics through acquisition of Trasir Therapeutics, Inc. Trasir’s innovative peptide-based OligoPhoreTM…
Evaxion Biotech Reports Preclinical Proof of Concept Data for Evaxion’s AI-powered Vaccine Platform RAVEN for the Design of a Next Generation SARS-CoV-2 Vaccine
COPENHAGEN, Denmark, June 03, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage…